See the DrugPatentWatch profile for vascepa

Vascepa (icosapent ethyl) is a prescription medication approved for the treatment of severe hypertriglyceridemia, or extremely high levels of triglycerides in the blood [1]. ACE inhibitors (angiotensin-converting enzyme inhibitors) are a class of drugs used primarily to treat hypertension (high blood pressure) and heart failure [2].

There are currently no well-documented or widely recognized interactions between Vascepa and ACE inhibitors [3]. However, it is always important for healthcare providers to be aware of all medications a patient is taking, as individual patient responses can vary. Patients should always consult with their healthcare provider or pharmacist for personalized advice regarding medication interactions.

It is also important to note that, although there are no known interactions between Vascepa and ACE inhibitors, both medications can have side effects and may interact with other medications, supplements, or health conditions [1][2]. Patients should be monitored for any adverse effects and should inform their healthcare provider of any changes in their health status or medications.

In summary, while there are no known significant interactions between Vascepa and ACE inhibitors, patients should always consult with their healthcare provider or pharmacist for personalized advice regarding medication interactions.

Sources:
[1] Vascepa (icosapent ethyl) [Prescribing Information]. Amarin Pharma, Inc.; 2021. <https://www.vascepa.com/-/media/Files/Vascepa/Prescribing-Information.pdf>
[2] ACE Inhibitors. Mayo Clinic. <https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/ace-inhibitors/art-20047451>
[3] DrugPatentWatch. Vascepa. <https://www.drugpatentwatch.com/drugs/vascepa>